(ARTNA) Artesian Resources - Overview
Stock: Water, Wastewater, Infrastructure, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.82% |
| Yield on Cost 5y | 2.69% |
| Yield CAGR 5y | 4.09% |
| Payout Consistency | 100.0% |
| Payout Ratio | 67.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.2% |
| Relative Tail Risk | -1.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | 4.00 |
| Character TTM | |
|---|---|
| Beta | -0.101 |
| Beta Downside | -0.129 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.31% |
| CAGR/Max DD | -0.32 |
Description: ARTNA Artesian Resources December 29, 2025
Artesian Resources Corporation (NASDAQ: ARTNA) is a regional water-utility that delivers potable water, wastewater collection, treatment, and related engineering services to residential, commercial, industrial, governmental, and municipal customers across Delaware, Maryland, and Pennsylvania. Its operations span 1,491 miles of transmission and distribution mains and include ancillary businesses such as real-estate holdings, storm-water system design, and contract services for other utilities.
Key quantitative points (2023-2024 public filings) that shape its financial outlook: • Revenue was approximately $260 million in 2023, with an EBITDA margin near 30 %-typical for regulated water utilities that benefit from stable cash flows. • The company’s regulated rate base sits around $1.2 billion, driving a modest but predictable return on equity under state-approved rate cases. • Capital expenditures have averaged $40 million annually, reflecting ongoing pipeline renewal and compliance with tightening environmental standards. Sector-wide, demand growth is anchored in population increases in the Mid-Atlantic, while climate-related resilience spending and stricter EPA wastewater regulations act as tailwinds for service-expansion and rate-case justifications.
For a deeper dive into ARTNA’s valuation metrics, peer benchmarks, and scenario analysis, you may find ValueRay’s dedicated profile a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 22.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 3.30 > 1.0 |
| NWC/Revenue: -8.41% < 20% (prev 5.97%; Δ -14.37% < -1%) |
| CFO/TA 0.04 > 3% & CFO 36.6m > Net Income 22.5m |
| Net Debt (174.7m) to EBITDA (52.8m): 3.31 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.3m) vs 12m ago 0.16% < -2% |
| Gross Margin: 46.36% > 18% (prev 0.50%; Δ 4586 % > 0.5%) |
| Asset Turnover: 13.72% > 50% (prev 13.27%; Δ 0.44% > 0%) |
| Interest Coverage Ratio: 4.47 > 6 (EBITDA TTM 52.8m / Interest Expense TTM 8.76m) |
Altman Z'' 0.79
| A: -0.01 (Total Current Assets 19.6m - Total Current Liabilities 29.0m) / Total Assets 833.9m |
| B: 0.11 (Retained Earnings 94.2m / Total Assets 833.9m) |
| C: 0.05 (EBIT TTM 39.1m / Avg Total Assets 815.0m) |
| D: 0.16 (Book Value of Equity 94.2m / Total Liabilities 585.1m) |
| Altman-Z'' Score: 0.79 = B |
Beneish M -3.32
| DSRI: 0.59 (Receivables 7.91m/12.7m, Revenue 111.8m/105.6m) |
| GMI: 1.08 (GM 46.36% / 50.26%) |
| AQI: 0.90 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 1.06 (Revenue 111.8m / 105.6m) |
| TATA: -0.02 (NI 22.5m - CFO 36.6m) / TA 833.9m) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of ARTNA shares?
Over the past week, the price has changed by -3.15%, over one month by +2.72%, over three months by +0.70% and over the past year by +7.28%.
Is ARTNA a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARTNA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46 | 42.4% |
| Analysts Target Price | 46 | 42.4% |
| ValueRay Target Price | 31.2 | -3.4% |
ARTNA Fundamental Data Overview February 03, 2026
P/E Forward = 17.8571
P/S = 3.0853
P/B = 1.3826
P/EG = 7.29
Revenue TTM = 111.8m USD
EBIT TTM = 39.1m USD
EBITDA TTM = 52.8m USD
Long Term Debt = 174.7m USD (from longTermDebt, last quarter)
Short Term Debt = 2.57m USD (from shortLongTermDebt, last quarter)
Debt = 174.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 174.7m USD (from netDebt column, last quarter)
Enterprise Value = 518.8m USD (344.9m + Debt 174.7m - CCE 705.0k)
Interest Coverage Ratio = 4.47 (Ebit TTM 39.1m / Interest Expense TTM 8.76m)
EV/FCF = 24.05x (Enterprise Value 518.8m / FCF TTM 21.6m)
FCF Yield = 4.16% (FCF TTM 21.6m / Enterprise Value 518.8m)
FCF Margin = 19.30% (FCF TTM 21.6m / Revenue TTM 111.8m)
Net Margin = 20.16% (Net Income TTM 22.5m / Revenue TTM 111.8m)
Gross Margin = 46.36% ((Revenue TTM 111.8m - Cost of Revenue TTM 60.0m) / Revenue TTM)
Gross Margin QoQ = 40.33% (prev 52.66%)
Tobins Q-Ratio = 0.62 (Enterprise Value 518.8m / Total Assets 833.9m)
Interest Expense / Debt = 1.26% (Interest Expense 2.19m / Debt 174.7m)
Taxrate = 26.21% (2.47m / 9.44m)
NOPAT = 28.9m (EBIT 39.1m * (1 - 26.21%))
Current Ratio = 0.68 (Total Current Assets 19.6m / Total Current Liabilities 29.0m)
Debt / Equity = 0.70 (Debt 174.7m / totalStockholderEquity, last quarter 248.8m)
Debt / EBITDA = 3.31 (Net Debt 174.7m / EBITDA 52.8m)
Debt / FCF = 8.10 (Net Debt 174.7m / FCF TTM 21.6m)
Total Stockholder Equity = 243.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.76% (Net Income 22.5m / Total Assets 833.9m)
RoE = 9.25% (Net Income TTM 22.5m / Total Stockholder Equity 243.6m)
RoCE = 9.35% (EBIT 39.1m / Capital Employed (Equity 243.6m + L.T.Debt 174.7m))
RoIC = 6.84% (NOPAT 28.9m / Invested Capital 422.1m)
WACC = 3.99% (E(344.9m)/V(519.5m) * Re(5.54%) + D(174.7m)/V(519.5m) * Rd(1.26%) * (1-Tc(0.26)))
Discount Rate = 5.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.15%
[DCF Debug] Terminal Value 85.85% ; FCFF base≈21.6m ; Y1≈20.6m ; Y5≈19.8m
Fair Price DCF = 44.45 (EV 593.9m - Net Debt 174.7m = Equity 419.3m / Shares 9.43m; r=5.90% [WACC]; 5y FCF grow -6.10% → 2.90% )
EPS Correlation: -9.08 | EPS CAGR: -46.97% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.68 | Revenue CAGR: 8.03% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=-0.040 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.00 | Chg30d=-0.210 | Revisions Net=+0 | Growth EPS=-8.3% | Growth Revenue=+3.5%